Stem Cell Manufacturing Market by Product (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables), Application (Research, Target Identification, Therapy (Autologous, Allogeneic), Cell Banks), End User (Pharma, Hospitals) – Global Forecast to 2023

◆상품코드 : BT-6089
◆발행일 : 2018년 3월
◆페이지수 : 171
◆보고서 형식 : PDF / 영문
◆납품 방식 : E메일
◆조사대상 지역 : 글로벌
◆산업분야 : 바이오
◆발행회사(조사회사) : MarketsandMarkets
◆판매회사 : H&I글로벌리서치(주)
◆판매가격 옵션
Single User¥632,800 -> 환산 ₩6,328,000견적의뢰/구매/질문FORM
Multi User (Five User)¥744,800 -> 환산 ₩7,448,000견적의뢰/구매/질문FORM
Corporate License¥912,800 -> 환산 ₩9,128,000견적의뢰/구매/질문FORM
※지불하실 금액은 상기금액이며, 세금 및 배송료는 없습니다.
※지불은 선불결제 방식이며, 신용카드결제 또는 계좌입금(국내/해외)이 선택가능합니다.
※구매의사를 FORM기입 또는 E메일로 연락주시면 담당자가 회신 드리겠습니다.
※배송은 입금 확인 후, E메일로 납품드리며, 일반적으로 당일~2일정도 소요됩니다.
※가격옵션 설명 : (Single User : 귀사내에서 1명만 사용가능 / Five User, Multi User : 귀사내에서 5명까지 사용가능 / Site License, Corporate License : 동일국내에서 인원제한없이 사용가능 / Global Site License, Enterprise License : 지역상관없이 인원제한없이 사용/공유 가능한 라이센스). 자세한 설명은 이용안내 페이지를 참고하세요.


[조사보고서 개요]

The global stem cell manufacturing market is projected to reach USD 14.61 Billion by 2023 from USD 10.75 Billion in 2018, at a CAGR of 6.3%. Factors such as growing public-private investments and funding in stem cell-based research, rising public awareness regarding about the therapeutic potency of stem cell products, development of advanced genomic analysis techniques for quality control during stem cell manufacturing, technological advancements in stem cell manufacturing and preservation, and evolving regulatory frameworks for stem cell therapeutics in the US and Europe are driving the growth of the market.

This report broadly segments the stem cell manufacturing market into product, application, end user, and region. On the basis of product, the market is categorized into culture media, consumables, instruments, and stem cell lines. In 2017, the culture media segment accounted for the largest share of the market. The large market share of this segment is attributed the rising stem cell research and increasing demand for stem cell therapies.

Based on application, the market is categorized into three segments, namely, research, clinical, and cell and tissue banking applications. In 2017, cell and tissue banking applications accounted for the largest share of the market. The dominant share of this segment is credited to the increasing public demand for cord blood stem cell banking and rising awareness regarding the prospective advantages of stem cell preservation.

On the basis of end user, the market is segmented into hospitals and surgical centers; pharmaceutical and biotech companies; cell banks and tissue banks; academic institutes, research laboratories, and CROs; and other end users. In 2017, the pharmaceutical and biotech companies accounted for the largest share of the market. The dominant share of this segment is credited to the rising public-private investments for stem cell-based research, ongoing patent expiry of branded drugs, and increasing patient preference for precision & regenerative medicines.

This report covers the market across four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). Of the four geographic regions studied in the report, North America accounted for the largest share of the market in 2017. The high intensity of stem cell research in the region, rising public-private funding and grants to support the clinical evaluation of stem cells for various applications, robust research infrastructure, and rising public awareness on the therapeutic potency of stem cells are driving the growth of the stem cell manufacturing market in North America. However, the Asia Pacific market is projected to register the highest CAGR during the forecast period. The high growth rate in this region can be attributed to the presence/implementation of supportive regulatory frameworks for stem cell research and manufacturing, ongoing expansion & modernization of healthcare infrastructure across emerging Asian countries, and increasing public-private initiatives to encourage public awareness about stem cell-based treatment.

Stem Cell Manufacturing Market

Factor such as significant operational costs associated with stem cell manufacturing & banking is expected to restrain the growth of the market during the forecast period.

The major players in the market are Thermo Fisher Scientific (US), Merck Group (Germany), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Miltenyi Biotec (Germany), Takara Bio Group (Japan), STEMCELL Technologies (Canada), Pharmicell (South Korea), Osiris Therapeutics (US), Anterogen (South Korea), Cellular Dynamics International (US), MEDIPOST (South Korea), Lonza Group (Switzerland), Holostem Terapie Avanzate (Italy), and Pluristem Therapeutics (Israel), among others.

[조사보고서 목차]

1 Introduction (Page No. – 13)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Geographic Scope
1.2.3 Years Considered for the Study
1.3 Currency Used
1.4 Market Stakeholders

2 Research Methodology (Page No. – 17)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Breakdown of Primaries
2.1.2.2 Key Data From Primary Sources
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations

3 Executive Summary (Page No. – 26)

4 Premium Insights (Page No. – 30)
4.1 Stem Cell Manufacturing: Market Overview (2018)
4.2 Global Stem Cell Manufacturing Market, By Product, 2018
4.3 Market, By Application and Region (2018)
4.4 Market, By End User (2018 vs 2023)
4.5 Geographic Snapshot: Stem Cell Manufacturing Market (2017)

5 Market Overview (Page No. – 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Growing Public-Private Investments and Funding in Stem Cell-Based Research
5.2.1.2 Growing Public Awareness About the Therapeutic Potency of Stem Cell Products
5.2.1.3 Development of Advanced Genomic Analysis Techniques for Quality Control During Stem Cell Manufacturing
5.2.1.4 Technological Advancements in Stem Cell Manufacturing and Preservation
5.2.1.5 Evolving Regulatory Frameworks for Stem Cell Therapeutics in the US and Europe
5.2.2 Market Restraints
5.2.2.1 Significant Operational Costs Associated With Stem Cell Manufacturing and Banking
5.2.3 Market Opportunities
5.2.3.1 Increased Market Focus on Embryonic Stem Cells (ESCS) and Induced Pluripotent Stem Cells (IPSCS)
5.2.3.2 Supportive Government Regulations Across Developing Countries
5.2.4 Market Challenges
5.2.4.1 Technical Limitations Associated With Manufacturing Scale-Up
5.2.4.2 Socio-Ethical Concerns Related to the Use of Allogenic and Human Embryonic Stem Cells
5.2.5 Research Pipeline Analysis: Stem Cell-Based Products/Therapies

6 Stem Cell Manufacturing Market, By Product (Page No. – 48)
6.1 Introduction
6.2 Stem Cell Lines
6.2.1 Induced Pluripotent Stem Cells
6.2.2 Embryonic Stem Cells
6.2.3 Multipotent Adult Progenitor Stem Cells
6.2.4 Mesenchymal Stem Cells
6.2.5 Hematopoietic Stem Cells
6.2.6 Neural Stem Cells
6.3 Instruments
6.3.1 Bioreactors and Incubators
6.3.2 Cell Sorters
6.3.3 Other Instruments
6.4 Culture Media
6.5 Consumables

7 Stem Cell Manufacturing Market, By Application (Page No. – 62)
7.1 Introduction
7.2 Research Applications
7.2.1 Drug Discovery and Development
7.2.2 Life Science Research
7.3 Clinical Applications
7.3.1 Allogenic Stem Cell Therapy
7.3.2 Autologous Stem Cell Therapy
7.4 Cell and Tissue Banking

8 Stem Cell Manufacturing Market, By End User (Page No. – 72)
8.1 Introduction
8.2 Pharmaceutical and Biotechnology Companies
8.3 Hospitals and Surgical Centers
8.4 Academic Institutes, Research Laboratories, and Cros
8.5 Cell Banks and Tissue Banks
8.6 Other End Users

9 Stem Cell Manufacturing Market, By Region (Page No. – 79)
9.1 Introduction
9.2 North America
9.2.1 US
9.3 Europe
9.4 Asia Pacific
9.5 Rest of the World

10 Competitive Landscape (Page No. – 102)
10.1 Overview
10.2 Market Ranking (2016)
10.3 Competitive Scenario
10.3.1 Product Launches, Upgrades, and Approvals
10.3.2 Agreements, Partnerships, and Collaborations
10.3.3 Acquisitions
10.3.4 Expansions

11 Company Profiles (Page No. – 107)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
11.1 Merck Group
11.2 Thermo Fisher Scientific
11.3 Becton, Dickinson and Company (BD)
11.4 Bio-Rad Laboratories
11.5 Miltenyi Biotec
11.6 Pharmicell
11.7 Takara Bio Group
11.8 Stemcell Technologies
11.9 Osiris Therapeutics
11.10 Anterogen
11.11 Cellular Dynamics International (Subsidiary of Fujifilm Holdings Corporation)
11.12 Medipost
11.13 Lonza Group
11.14 Holostem Terapie Avanzate
11.15 Pluristem Therapeutics

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. – 160)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Introducing RT: Real-Time Market Intelligence
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details

List of Tables (69 Tables)

Table 1 Key Genome-Based Cell Analysis Products Launched During 2014–2017
Table 2 Global Stem Cell Manufacturing Market, By Product, 2016-2023 (USD Million)
Table 3 Global Market for Stem Cell Lines, By Type, 2016-2023 (USD Million)
Table 4 Market for Stem Cell Lines, By Region, 2016-2023 (USD Million)
Table 5 Key Expansion and Differentiation Technologies to Extract Human-Induced Pluripotent Stem Cell Lines
Table 6 Induced Pluripotent Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 7 Embryonic Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 8 Multipotent Adult Progenitor Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 9 Mesenchymal Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 10 Hematopoietic Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 11 Neural Stem Cells Market, By Region, 2016-2023 (USD Million)
Table 12 Global Market for Instruments, By Type, 2016-2023 (USD Million)
Table 13 Market for Instruments, By Region, 2016-2023 (USD Million)
Table 14 Market for Bioreactors & Incubators, By Region, 2016-2023 (USD Million)
Table 15 Market for Cell Sorters, By Region, 2016-2023 (USD Million)
Table 16 Market for Other Instruments, By Region, 2016-2023 (USD Million)
Table 17 Market Fort Culture Media, By Region, 2016-2023 (USD Million)
Table 18 Market for Consumables, By Region, 2016-2023 (USD Million)
Table 19 Stem Cell Manufacturing Market, By Application, 2016–2023 (USD Million)
Table 20 Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 21 Stem Cell Manufacturing Market for Research Applications, By Region, 2016–2023 (USD Million)
Table 22 Market for Drug Discovery and Development, By Region, 2016–2023 (USD Million)
Table 23 Market for Life Science Research, By Region, 2016–2023 (USD Million)
Table 24 Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 25 Market for Clinical Applications, By Region, 2016–2023 (USD Million)
Table 26 Market for Allogenic Stem Cell Therapy, By Region, 2016–2023 (USD Million)
Table 27 Market for Autologous Stem Cell Therapy, By Region, 2016–2023 (USD Million)
Table 28 Market for Cell & Tissue Banking, By Region, 2016–2023 (USD Million)
Table 29 Market, By End User, 2016–2023 (USD Million)
Table 30 Market for Pharmaceutical and Biotechnology Companies, By Region, 2016–2023 (USD Million)
Table 31 Market for Hospitals and Surgical Centers, By Region, 2016–2023 (USD Million)
Table 32 Market for Academic Institutes, Research Laboratories, and Cros, By Region, 2016–2023 (USD Million)
Table 33 Market for Cell Banks and Tissue Banks, By Region, 2016–2023 (USD Million)
Table 34 Market for Other End Users, By Region, 2016–2023 (USD Million)
Table 35 Market, By Region, 2016–2023 (USD Million)
Table 36 North America: Market, By Product, 2016–2023 (USD Million)
Table 37 North America: Market for Stem Cell Lines, By Type, 2016–2023 (USD Million)
Table 38 North America: Market for Instruments, By Type, 2016–2023 (USD Million)
Table 39 North America: Market, By Application, 2016–2023 (USD Million)
Table 40 North America: Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 41 North America: Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 42 North America: Market, By End User, 2016–2023 (USD Million)
Table 43 US: Market, By Product, 2016–2023 (USD Million)
Table 44 US: Market for Stem Cell Lines, By Type, 2016–2023 (USD Million)
Table 45 Europe: Market, By Product, 2016–2023 (USD Million)
Table 46 Europe: Market for Stem Cell Lines, By Type, 2016–2023 (USD Million)
Table 47 Europe: Market for Instruments, By Type, 2016–2023 (USD Million)
Table 48 Europe: Market, By Application, 2016–2023 (USD Million)
Table 49 Europe: Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 50 Europe: Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 51 Europe: Market, By End User, 2016–2023 (USD Million)
Table 52 Asia Pacific: Stem Cell Manufacturing Market, By Product, 2016–2023 (USD Million)
Table 53 Asia Pacific: Market for Stem Cell Lines, By Type, 2016–2023 (USD Million)
Table 54 Asia Pacific: Market for Instruments, By Type, 2016–2023 (USD Million)
Table 55 Asia Pacific: Market, By Application, 2016–2023 (USD Million)
Table 56 Asia Pacific: Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 57 Asia Pacific: Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 58 Asia Pacific: Market, By End User, 2016–2023 (USD Million)
Table 59 RoW: Market, By Product, 2016–2023 (USD Million)
Table 60 RoW: Market for Stem Cell Lines, By Type, 2016–2023 (USD Million)
Table 61 RoW: Market for Instruments, By Type, 2016–2023 (USD Million)
Table 62 RoW: Market, By Application, 2016–2023 (USD Million)
Table 63 RoW: Market for Research Applications, By Type, 2016–2023 (USD Million)
Table 64 RoW: Market for Clinical Applications, By Type, 2016–2023 (USD Million)
Table 65 RoW: Market, By End User, 2016–2023 (USD Million)
Table 66 Key Product Launches, Upgrades, and Approvals, 2014–2017
Table 67 Key Agreements, Partnerships, and Collaborations, 2014–2017
Table 68 Key Acquisitions, 2014–2017
Table 69 Key Expansions, 2014–2017

List of Figures (33 Figures)

Figure 1 Global Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Stem Cell Manufacturing Market: Bottom-Up Approach
Figure 4 Market: Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Culture Media Segment to Dominate the Global Stem Cell Manufacturing Market During Forecast Period
Figure 7 Research Applications Segment to Dominate the Market During Forecast Period
Figure 8 Cell and Tissue Banks to Be the Fastest-Growing End-User Segment During 2018-2023
Figure 9 Asia Pacific to Grow at the Highest Rate in the Forecast Period
Figure 10 Rising Public-Private Investments and Funding for Stem Cell-Based Research to Drive Market Growth
Figure 11 Culture Media Segment to Dominate the Global Stem Cell Manufacturing Market During the Forecast Period
Figure 12 North America to Dominate the Market, By Application, in 2018
Figure 13 Cell Banks and Tissue Banks to Be Fastest-Growing Segment During the Forecast Period
Figure 14 North America to Dominate the Global Stem Cell Manufacturing Market During the Forecast Period
Figure 15 Stem Cell Manufcaturing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 16 Stem Cell Lines to Be the Fastest-Growing Segment During 2018-2023
Figure 17 Stem Cell Manufacturing Market, By Application, 2018 vs 2023
Figure 18 Market, By End User, 2018 vs 2023
Figure 19 Geographic Snapshot: Asia Pacific to Be the Fastest Growing Region in Stem Cell Manufacturing Market During the Forecast Period
Figure 20 North America: Market Snapshot
Figure 21 Europe: Market Snapshot
Figure 22 Asia Pacific: Market Snapshot
Figure 23 RoW: Market Snapshot
Figure 24 Global Market Ranking Analysis, By Key Players (2016)
Figure 25 Merck Group: Company Snapshot (2016)
Figure 26 Thermo Fisher Scientific: Company Snapshot (2016)
Figure 27 BD: Company Snapshot (2017)
Figure 28 Bio-Rad Laboratories: Company Snapshot (2016)
Figure 29 Takara Bio Group: Company Snapshot (2017)
Figure 30 Fujifilm Holdings Corporation: Company Snapshot (2017)
Figure 31 Medipost: Company Snapshot (2016)
Figure 32 Lonza Group: Company Snapshot (2016)
Figure 33 Pluristem Therapeutics: Company Snapshot (2016)



[보고서에 포함된 내용]
세계시장규모, 세그멘트별 시장규모, 시장동향, 시장예측, 관련 기업정보 등

[면책사항]
http://www.globalresearch.kr/disclaimer

★조사보고서 [Stem Cell Manufacturing Market by Product (HSCs, MSCs, iPSCs, ESCs, Instruments, Media, Consumables), Application (Research, Target Identification, Therapy (Autologous, Allogeneic), Cell Banks), End User (Pharma, Hospitals) – Global Forecast to 2023]에 관해서 E메일 문의 연락
◆H&I글로벌리서치의 고객기업(예)◆